<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lisinopril and increased risk of stroke</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lisinopril and increased risk of stroke</h1>
<div class="graphic"><div class="figure"><div class="ttl">Lisinopril and increased risk of stroke</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In the ALLHAT trial, cumulative event rates for the development of stroke according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there was a significant increase in the six year rate of stroke with lisinopril (6.3 versus 5.6 percent, relative risk 1.15 95 percent CI 1.02 to 1.30).</div><div class="graphic_reference">Data from The ALLHAT Officers, JAMA 2002; 288:2981.</div><div id="graphicVersion">Graphic 61612 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
